ASCVD MANAGEMENT
Clinical trials for ASCVD MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new ASCVD MANAGEMENT trials appear
Sign up with your email to follow new studies for ASCVD MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a single drug calm inflamed arteries in people with a common gene mutation?
Disease control Recruiting nowThis study tests whether the drug canakinumab can reduce inflammation in the blood vessels of people who have had a heart attack or a stent placed. It includes people with and without a specific genetic change called TET2 clonal hematopoiesis. The goal is to see if the drug lower…
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 07:37 UTC
-
New drug aims to melt artery plaque in heart patients
Disease control Recruiting nowThis study tests an experimental drug called ABP-745 in 200 adults with atherosclerosis (hardening of the arteries due to plaque buildup). The goal is to see if it can reduce plaque in the arteries better than a placebo. Participants will receive the drug or placebo for 52 weeks,…
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Pharmacy helpers take on high cholesterol in heart patients
Disease control Recruiting nowThis study tests whether pharmacy staff can help people with heart disease and high cholesterol reach their LDL (bad cholesterol) goals. About 1,000 adults will get phone calls to review their medications, labs, and appointments, and their cholesterol drugs may be adjusted. The g…
Matched conditions: ASCVD MANAGEMENT
Sponsor: University of Texas at Austin • Aim: Disease control
Last updated May 07, 2026 18:43 UTC